In vitro antibacterial activity of enoxacin, a new pyridonecarboxylic acid.
U Fabio, Moreno Bondi, Ferruccio Galletti, Gian Carlo Manicardi, Patrizia Messi, Rachele Giovanna Neglia, Chiara Casolari
Abstract
U Fabio, Moreno Bondi, Ferruccio Galletti, Gian Carlo Manicardi, Patrizia Messi, Rachele Giovanna Neglia, Chiara Casolari
Abstract
The antibacterial activity of enoxacin was determined against 1015 strains of Gram-positive and Gram-negative bacteria, mainly freshly isolated from clinical specimens. The minimum inhibitory concentrations (MIC 50-75-90) were determined in comparison to three commonly used antibiotics: ampicillin, cefotaxime and gentamicin. Enoxacin has shown a broad spectrum of action and antibacterial activity in general higher that than of three currently available antibiotics. The antibacterial activity seems similar to that of other quinolones of second generation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The antibacterial activity of enoxacin was determined against 1015 strains of Gram-positive and Gram-negative bacteria, mainly freshly isolated from clinical specimens. The minimum inhibitory concentrations (MIC 50-75-90) were determined in comparison to three commonly used antibiotics: ampicillin, cefotaxime and gentamicin. Enoxacin has shown a broad spectrum of action and antibacterial activity in general higher that than of three currently available antibiotics. The antibacterial activity seems similar to that of other quinolones of second generation.
Key concepts: Enoxacin, Antibacterial activity, Cefotaxime, Ampicillin, Antibiotics, Gentamicin, Microbiology, Chemistry